|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
WO2000032233A2
(en)
*
|
1998-12-03 |
2000-06-08 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
MXPA01010124A
(es)
*
|
1999-04-09 |
2002-06-26 |
Aventis Pharma Sa |
Composiciones destinada a la conservacion de adenovirus recombinantes infecciosos.
|
|
FR2791999B1
(fr)
*
|
1999-04-09 |
2001-09-07 |
Aventis Pharma Sa |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
WO2001066137A1
(en)
*
|
2000-03-07 |
2001-09-13 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
US7456009B2
(en)
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
US20040101964A1
(en)
*
|
2000-05-10 |
2004-05-27 |
Shigemitsu Takashima |
Method of preparing virus vector
|
|
EP1453536A4
(en)
|
2001-12-12 |
2009-08-26 |
Mayne Pharma Int Pty Ltd |
COMPOSITION FOR PRESERVING VIRUSES
|
|
PL371261A1
(en)
*
|
2002-01-18 |
2005-06-13 |
Schering Aktiengesellschaft |
Stabilized formulations of adenovirus
|
|
KR100507794B1
(ko)
*
|
2003-02-11 |
2005-08-17 |
한미약품 주식회사 |
고농도 레트로 바이러스 현탁액 제조 방법
|
|
WO2005052116A2
(en)
*
|
2003-11-19 |
2005-06-09 |
Merck & Co., Inc. |
Preservative-containing virus formulations
|
|
NZ548495A
(en)
*
|
2004-02-23 |
2009-05-31 |
Crucell Holland Bv |
Virus purification methods
|
|
GB0502661D0
(en)
*
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
EP1869171B2
(en)
*
|
2005-04-11 |
2015-10-14 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
CN1961961B
(zh)
*
|
2005-11-11 |
2010-05-26 |
深圳市源兴生物医药科技有限公司 |
一种药物制剂及其制备方法
|
|
ES2532015T3
(es)
|
2008-11-03 |
2015-03-23 |
Crucell Holland B.V. |
Método para la producción de vectores adenovíricos
|
|
DK2536829T3
(en)
|
2010-02-15 |
2016-07-04 |
Crucell Holland Bv |
A process for the production of Ad26-adenovirus vectors
|
|
AP3390A
(en)
|
2010-09-20 |
2015-08-31 |
Crucell Holland Bv |
Therapeutic vaccination against active tuberculosis
|
|
CA2809463C
(en)
|
2010-09-27 |
2021-05-25 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
|
MX349294B
(es)
*
|
2010-12-02 |
2017-07-21 |
Oncolytics Biotech Inc |
Formulaciones virales liofilizadas.
|
|
TW201233802A
(en)
|
2010-12-02 |
2012-08-16 |
Oncolytics Biotech Inc |
Liquid viral formulations
|
|
HUE027839T2
(en)
|
2012-03-12 |
2016-11-28 |
Crucell Holland Bv |
Recombinant adenoviruses with altered terminals
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
US9119813B2
(en)
|
2012-03-22 |
2015-09-01 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
SG11201405803PA
(en)
|
2012-03-22 |
2014-11-27 |
Crucell Holland Bv |
Vaccine against rsv
|
|
MX366206B
(es)
|
2012-07-10 |
2019-07-02 |
Transgene Sa |
Vacuna de antígeno micobacteriano.
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
KR102236497B1
(ko)
|
2013-04-25 |
2021-04-06 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 가용성 예비융합 ｒｓｖ ｆ 폴리펩타이드
|
|
MX362792B
(es)
|
2013-06-17 |
2019-02-13 |
Janssen Vaccines & Prevention Bv |
Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados.
|
|
MX2016009072A
(es)
|
2014-01-09 |
2017-05-08 |
Transgene Sa |
Fusion de antigenos micobacterianos heterooligomericos.
|
|
US9721484B2
(en)
|
2014-06-23 |
2017-08-01 |
Humanetics Innovative Solutions, Inc. |
Shoulder kit assembly for crash test dummy
|
|
PT3169341T
(pt)
|
2014-07-16 |
2019-09-09 |
Transgene Sa |
Vírus oncolítico para a expressão de moduladores de pontos de controlo imunitário
|
|
US10008130B2
(en)
|
2014-09-17 |
2018-06-26 |
Humanetics Innovative Solutions, Inc. |
Omni-directional shoulder assembly for crash test dummy
|
|
CN107949397A
(zh)
|
2015-02-13 |
2018-04-20 |
特兰斯吉恩股份有限公司 |
免疫治疗疫苗和抗体组合治疗
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
EP3283634B1
(en)
|
2015-04-14 |
2019-05-22 |
Janssen Vaccines & Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
WO2017005844A1
(en)
|
2015-07-07 |
2017-01-12 |
Janssen Vaccines & Prevention B.V. |
Vaccine against rsv
|
|
AU2016289496B2
(en)
|
2015-07-07 |
2021-02-04 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion RSV F polypeptides
|
|
KR102401247B1
(ko)
|
2016-04-05 |
2022-05-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
Rsv에 대한 백신
|
|
IL262108B2
(en)
|
2016-04-05 |
2023-04-01 |
Janssen Vaccines Prevention B V |
Soluble pre-fusion rsv f proteins are stabilized
|
|
CA3023322C
(en)
|
2016-05-12 |
2024-11-05 |
Janssen Vaccines & Prevention B.V. |
POWERFUL AND BALANCED BIDIRECTIONAL PROMOTER
|
|
MX2018014699A
(es)
|
2016-05-30 |
2019-02-28 |
Janssen Vaccines & Prevention Bv |
Proteinas f de prefusion del vrs estabilizadas.
|
|
MX393584B
(es)
|
2016-06-20 |
2025-03-21 |
Janssen Vaccines & Prevention Bv |
Promotor bidireccional potente y equilibrado.
|
|
JP7229151B2
(ja)
|
2016-07-14 |
2023-02-27 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
Ｈｐｖワクチン
|
|
TW201825511A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現免疫檢查點調節子的溶瘤病毒
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
AU2017387549B2
(en)
|
2016-12-28 |
2023-07-06 |
Transgene Sa |
Oncolytic viruses and therapeutic molecules
|
|
NZ755252A
(en)
|
2017-02-09 |
2022-05-27 |
Janssen Vaccines & Prevention Bv |
Potent and short promoter for expression of heterologous genes
|
|
AU2018267971A1
(en)
|
2017-05-17 |
2019-11-07 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against RSV infection
|
|
WO2018210871A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
MX2020002876A
(es)
|
2017-09-15 |
2020-07-22 |
Janssen Vaccines & Prevention Bv |
Metodo para la induccion segura de inmunidad contra el vsr.
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
JP7557738B2
(ja)
|
2018-10-30 |
2024-09-30 |
国立大学法人 東京大学 |
がん治療のための腫瘍溶解性ウイルス
|
|
JP2022513025A
(ja)
|
2018-11-13 |
2022-02-07 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
安定化された融合前ｒｓｖ ｆタンパク質
|
|
BR112022014808A2
(pt)
|
2020-01-31 |
2022-09-20 |
Beth Israel Deaconess Medical Ct Inc |
Composições e métodos para vacinas para prevenir e tratar infecção pelo coronavírus-sars-cov-2
|
|
KR20230013021A
(ko)
|
2020-03-19 |
2023-01-26 |
트리젤 엘티디. |
온도-반응성 바이러스 저장 시스템
|
|
KR20230038496A
(ko)
|
2020-07-13 |
2023-03-20 |
트랜스진 |
면역 억제의 치료
|
|
CN119487066A
(zh)
|
2021-02-01 |
2025-02-18 |
羿尊生物医药（浙江）有限公司 |
一种靶向蛋白降解系统及其应用
|
|
KR20230147156A
(ko)
|
2021-02-19 |
2023-10-20 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 융합 전 rsv fb 항원
|
|
WO2023020939A1
(en)
|
2021-08-17 |
2023-02-23 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
WO2023111725A1
(en)
|
2021-12-14 |
2023-06-22 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
WO2024003353A1
(en)
|
2022-07-01 |
2024-01-04 |
Transgene |
Fusion protein comprising a surfactant-protein-d and a member of the tnfsf
|
|
WO2024038175A1
(en)
|
2022-08-18 |
2024-02-22 |
Transgene |
Chimeric poxviruses
|